Latest Breaking News On - அரங்கு அமைப்பு - Page 1 : comparemela.com

EAU 2021: KEYNOTE-564: Phase 3 Trial of Pembrolizumab in the Adjuvant Treatment of Renal Cell Carcinoma Discussion

EAU 2021: KEYNOTE-564: Phase 3 Trial of Pembrolizumab in the Adjuvant Treatment of Renal Cell Carcinoma Discussion
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

Alberto bredaEuropean association of urologyEuropean associationStaging systemHigh risk renal cell carcinomaஆல்பர்டோ ப்ரேடாஐரோப்பிய சங்கம் ஆஃப் சிறுநீரகம்ஐரோப்பிய சங்கம்அரங்கு அமைப்பு

Ping An AskBob Doctor s Research on Risk Prediction Approach to Tailor Cancer Treatments Published in International Journal JNCI

Press release content from PR Newswire. The AP news staff was not involved in its creation. Ping An AskBob Doctor’s Research on Risk Prediction Approach to Tailor Cancer Treatments Published in International Journal JNCI March 9, 2021 GMT HONG KONG and SHANGHAI, March 9, 2021 /PRNewswire/ Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An” or the “Group”, HKEX: 2318; SSE: 601318) is pleased to announce that promising research on the artificial intelligence (AI) technology of Ping An AskBob Doctor has been published in The University of Oxford’s Journal of the National Cancer Institute (JNCI), an important international journal of oncology. The research shows the AI system can effectively categorize nasopharyngeal cancer (NPC) patients by risk level to recommend more refined treatment solutions.

Ping anHong kongGuotong xieMillward brown brandHealthcare scientist of ping an groupPing an healthcare technologyPing an groupNeural networksSun yat sen university cancer centerPing an askbob doctorNational cancer institutePing an smart cityPing an good doctorPrognostic predictive system basedDeep learningLocoregionally advanced nasopharyngeal

Ping An AskBob Doctor s Research on Risk Prediction Approach to Tailor Cancer Treatments Published in International Journal JNCI

Ping An AskBob Doctor s Research on Risk Prediction Approach to Tailor Cancer Treatments Published in International Journal JNCI
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Ping anHong kongGuotong xieMillward brown brandHealthcare scientist of ping an groupPing an healthcare technologyPing an groupNeural networksSun yat sen university cancer centerPing an askbob doctorNational cancer institutePing an smart cityPing an good doctorPrognostic predictive system basedDeep learningLocoregionally advanced nasopharyngeal

ESOU 2021: Surgical and Perioperative Challenges of Large Renal Tumors

ESOU 2021: Surgical and Perioperative Challenges of Large Renal Tumors (UroToday.com) At the European Association of Urology (EAU) Section of Oncological Urology (ESOU) 2021 virtual meeting, Dr. Arnaud Mejean discussed surgical and perioperative challenges of large renal tumors, particularly those with vena cava and lymph node involvement. Dr. Mejean notes that statistics from the SEER database suggest that 19% of patients present with locoregional disease, making this an important area of management. Historical data from an international multicenter study shows that based on UCLA Integrated Staging System (UISS) stratification for localized renal cell carcinoma (RCC), the 5-year survival rates were 92%, 67%, and 44% for low-, intermediate-, and high-risk groups, respectively.

United statesFrance generalZachary klaassenArnaud mejeanUniversity of california los angelesEuropean association of urologyGeorgia cancer centerAugusta university medical college of georgiaEuropean associationOncological urologyStaging systemUrologic oncologistAssistant professorMedical collegeCalifornia los angelesஒன்றுபட்டது மாநிலங்களில்